Casana and Massachusetts General Hospital (MGH) Cardiovascular Disease Prevention Center (CVDPC) have successfully conducted a collaborative research study titled “Validation of a novel toilet seat-based cuffless blood pressure measurement technology and association with left ventricular mass index” using the Heart Seat.
The study aimed to establish the correlation between seat-derived blood pressure (BP) and cuff-derived BPs obtained during routine clinical visits for cardiac rehabilitation (CR). Additionally, the researchers examined the association between seat-derived BP and left ventricular (LV) mass.
Each subject enrolled underwent a minimum of three and a maximum of four study visits, during which their blood pressure was measured using the following methods:
- Blood pressure cuff
- Heart Seat while sitting on the device
The study has now concluded, providing insights into the effectiveness of the Heart Seat as a reliable and non-intrusive method for measuring blood pressure.
Recommended insights
Casana Raises $14 Million in Series A Funding Led by General Catalyst for In-home Heart Health Monitoring Device
Company funded to develop visionary integrated IoT heart health device, in a toilet seat. Seasoned tech executive Austin McChord takes the helm as CEO
Boldly Growing: A Start-Up Founder’s Guide to Sustainable Success
Austin led the company through its acquisition by Vista Equity Partners in 2017, and subsequent $4B+ IPO in 2020. Austin is a Forbes 30 Under 30, was named Ernst & Young Technology Entrepreneur of the Year in 2016, and earned recognition as one of the nation's top 50 philanthropists in 2017.
A startup that monitors heart health with a toilet seat joins Innovators’ Network
Heart Health Intelligence is the latest member of the American Heart Association’s Center for Health Technology & Innovation Innovators’ Network